Correlation Between Eliem Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Aerovate Therapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Eliem and Aerovate is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Aerovate Therapeutics. In addition to that, Eliem Therapeutics is 1.14 times more volatile than Aerovate Therapeutics. It trades about -0.38 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.26 per unit of volatility. If you would invest 210.00 in Aerovate Therapeutics on August 25, 2024 and sell it today you would earn a total of 56.00 from holding Aerovate Therapeutics or generate 26.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Eliem Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Aerovate Therapeutics |
Eliem Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. RenovoRx | Aerovate Therapeutics vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |